Thalocan Research Innovations CEO Eric Zudak is heading to New York City, July 16–19, for The 2026 AAD Innovation Academy, a unique program packed with the latest breakthroughs in dermatology.

The AAD Innovation Academy delivers cutting-edge clinical insights and meaningful networking moments. One breakthrough sure to be discussed is the enthusiastic response to our Lesion Area Mapping Assistant (LAMA.)

LAMA is Thalocan’s cloud-based solution for enhancing lesion assessment in dermatologic clinical trials. Investigators can securely capture clinical images, map lesions, and document severity assessments using their own device or a study-provided tablet. LAMA enables real-time data sharing among investigators, CROs, and sponsors, with time-lapse review of treatment responses.

Other features include precise lesion mapping, standardized notations and numerous other tools to improve accuracy and data quality. Learn more about LAMA here.

Or just ask Eric Zudak to fill you in at AAD Innovation Academy 2026!